Rapamycin limits the growth of established experimental abdominal aortic aneurysms

European Journal of Vascular and Endovascular Surgery

Volumn 47, Issue 5, 2014, Pages 493-500

  Rouer, M ^a   Xu, B H ^a   Xuan, H J ^a   Tanaka, H ^a   Fujimura, N ^a   Glover, K J ^a   Furusho, Y ^a   Gerritsen, M ^a   Dalman, R L ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Abdominal aortic aneurysm; Angiogenesis; Macrophage; Rapamycin

Indexed keywords

CHEMOKINE RECEPTOR CCR2; ELASTIN; PANCREATIC ELASTASE; RAPAMYCIN;

ABDOMINAL AORTA ANEURYSM; ANEURYSM RUPTURE; ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; AORTA; ARTICLE; ATHEROSCLEROSIS; CELL INFILTRATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE COURSE; FOLLOW UP; MACROPHAGE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; SMOOTH MUSCLE FIBER;

ABDOMINAL AORTIC ANEURYSM; ANGIOGENESIS; MACROPHAGE; RAPAMYCIN;

ANIMALS; AORTIC ANEURYSM, ABDOMINAL; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; IMMUNOSUPPRESSIVE AGENTS; MALE; MICE; MICE, INBRED C57BL; NEOVASCULARIZATION, PATHOLOGIC; SIROLIMUS; TREATMENT OUTCOME;

EID: 84898814948     PISSN: 10785884     EISSN: 15322165     Source Type: Journal    
DOI: 10.1016/j.ejvs.2014.02.006     Document Type: Article

References (61)

1. K.C. Kent, R.M. Zwolak, N.N. Egorova, T.S. Riles, A. Manganaro, and A.J. Moskowitz et al. Analysis of risk factors for abdominal aortic aneurysm in a cohort of more than 3 million individuals J Vasc Surg 52 3 2010 539 548
2. J.B. Michel, J.L. Martin-Ventura, J. Egido, N. Sakalihasan, V. Treska, and J. Lindholt et al. Novel aspects of the pathogenesis of aneurysms of the abdominal aorta in humans Cardiovasc Res 90 1 2011 18 27
3. W. Xiong, J. MacTaggart, R. Knispel, J. Worth, Y. Persidsky, and B.T. Baxter Blocking TNF-alpha attenuates aneurysm formation in a murine model J Immunol 183 4 2009 2741 2746
4. G. Marinkovic, S. Hibender, M. Hoogenboezem, A. van Broekhoven, A.F. Girigorie, and N. Bleeker et al. Immunosuppressive drug azathioprine reduces aneurysm progression through inhibition of Rac1 and c-Jun-terminal-N-kinase in endothelial cells Arterioscler Thromb Vasc Biol 33 10 2013 2380 2388
5. J. Dai, S. Michineau, G. Franck, P. Desgranges, J.P. Becquemin, and M. Gervais et al. Long term stabilization of expanding aortic aneurysms by a short course of cyclosporine A through transforming growth factor-beta induction PLoS One 6 12 2011 e28903
6. T. Miyake, M. Aoki, H. Masaki, T. Kawasaki, M. Oishi, and K. Kataoka et al. Regression of abdominal aortic aneurysms by simultaneous inhibition of nuclear factor kappaB and ets in a rabbit model Circ Res 101 11 2007 1175 1184
7. K. Yoshimura, H. Aoki, Y. Ikeda, K. Fujii, N. Akiyama, and A. Furutani et al. Regression of abdominal aortic aneurysm by inhibition of c-Jun N-terminal kinase Nat Med 11 12 2005 1330 1338
8. Y. Iida, B. Xu, H. Xuan, K.J. Glover, H. Tanaka, and X. Hu et al. Peptide inhibitor of CXCL4-CCL5 heterodimer formation, MKEY, inhibits experimental aortic aneurysm initiation and progression Arterioscler Thromb Vasc Biol 33 4 2013 718 726
9. X. Xie, H. Lu, J.J. Moorleghen, D.A. Howatt, D.L. Rateri, and L.A. Cassis et al. Doxycycline does not influence established abdominal aortic aneurysms in angiotensin II-infused mice PLoS One 7 9 2012 e46411
10. S. Ghoshal, and C.D. Loftin Cyclooxygenase-2 inhibition attenuates abdominal aortic aneurysm progression in hyperlipidemic mice PLoS One 7 11 2012 e44369
11. R.L. Dalman, M.M. Tedesco, J. Myers, and C.A. Taylor AAA disease: mechanism, stratification, and treatment Ann N Y Acad Sci 1085 2006 92 109
12. J. Golledge, and P.E. Norman Current status of medical management for abdominal aortic aneurysm Atherosclerosis 217 1 2011 57 63
13. E.L. Chaikof, D.C. Brewster, R.L. Dalman, M.S. Makaroun, K.A. Illig, and G.A. Sicard et al. The care of patients with an abdominal aortic aneurysm: the Society for Vascular Surgery practice guidelines J Vasc Surg 50 Suppl. 4 2009 S2 S49
14. S.J. Patel, E.N. Elliott, R.J. Knight, L.W. Gaber, and A.O. Gaber Considerations in sirolimus use in the early and late post-transplant periods Expert Opin Drug Saf 8 4 2009 421 434
15. W. Khan, S. Farah, and A.J. Domb Drug eluting stents: developments and current status J Control Release 161 2 2012 703 712
16. M. Laplante, and D.M. Sabatini mTOR signaling in growth control and disease Cell 149 2 2012 274 293
17. W.Q. Chen, L. Zhong, L. Zhang, X.P. Ji, M. Zhang, and Y.X. Zhao et al. Oral rapamycin attenuates inflammation and enhances stability of atherosclerotic plaques in rabbits independent of serum lipid levels Br J Pharmacol 156 6 2009 941 951
18. C. Castro, J.M. Campistol, D. Sancho, F. Sánchez-Madrid, E. Casals, and V. Andrés Rapamycin attenuates atherosclerosis induced by dietary cholesterol in apolipoprotein-deficient mice through a p27 Kip1-independent pathway Atherosclerosis 172 1 2004 31 38
19. M.M. Elloso, N. Azrolan, S.N. Sehgal, P.L. Hsu, K.L. Phiel, and C.A. Kopec et al. Protective effect of the immunosuppressant sirolimus against aortic atherosclerosis in apo E-deficient mice Am J Transplant 3 5 2003 562 569
20. D.M. Lawrence, R.S. Singh, D.P. Franklin, D.J. Carey, and J.R. Elmore Rapamycin suppresses experimental aortic aneurysm growth J Vasc Surg 40 2 2004 334 338
21. C.S. Moran, R.J. Jose, J.V. Moxon, A. Roomberg, P.E. Norman, and C. Rush et al. Everolimus limits aortic aneurysm in the apolipoprotein E-deficient mouse by downregulating C-C chemokine receptor 2 positive monocytes Arterioscler Thromb Vasc Biol 33 4 2013 814 821
22. Y. Iida, B. Xu, G.M. Schultz, V. Chow, J.J. White, and S. Sulaimon et al. Efficacy and mechanism of angiotensin II receptor blocker treatment in experimental abdominal aortic aneurysms PLoS One 7 12 2012 e49642
23. A.K. Sharma, G. Lu, A. Jester, W.F. Johnston, Y. Zhao, and V.A. Hajzus et al. Experimental abdominal aortic aneurysm formation is mediated by IL-17 and attenuated by mesenchymal stem cell treatment Circulation 126 11 Suppl. 1 2012 S38 S45
24. H. Lu, D.L. Rateri, D. Bruemmer, L.A. Cassis, and A. Daugherty Novel mechanisms of abdominal aortic aneurysms Curr Atheroscler Rep 14 5 2012 402 412
25. W.F. Johnston, M. Salmon, G. Su, G. Lu, M.L. Stone, and Y. Zhao et al. Genetic and pharmacologic disruption of interleukin-1beta signaling inhibits experimental aortic aneurysm formation Arterioscler Thromb Vasc Biol 33 2 2013 294 304
26. E. Sho, M. Sho, K. Hoshina, K. Hoshina, H. Kimura, and T.K. Nakahashi et al. Hemodynamic forces regulate mural macrophage infiltration in experimental aortic aneurysms Exp Mol Pathol 76 2 2004 108 116
27. A. Daugherty, D.L. Rateri, I.F. Charo, A.P. Owens, D.A. Howatt, and L.A. Cassis Angiotensin II infusion promotes ascending aortic aneurysms: attenuation by CCR2 deficiency in apoE-/- mice Clin Sci (Lond) 118 11 2010 681 689
28. V. de Waard, I. Bot, S.C. de Jager, S. Talib, K. Egashira, and M.R. de Vries et al. Systemic MCP1/CCR2 blockade and leukocyte specific MCP1/CCR2 inhibition affect aortic aneurysm formation differently Atherosclerosis 211 1 2010 84 89
29. M. Ishibashi, K. Egashira, Q. Zhao, K. Hiasa, K. Ohtani, and Y. Ihara et al. Bone marrow-derived monocyte chemoattractant protein-1 receptor CCR2 is critical in angiotensin II-induced acceleration of atherosclerosis and aneurysm formation in hypercholesterolemic mice Arterioscler Thromb Vasc Biol 24 11 2004 e174 e178
30. J.N. MacTaggart, W. Xiong, R. Knispel, and B.T. Baxter Deletion of CCR2 but not CCR5 or CXCR3 inhibits aortic aneurysm formation Surgery 142 2 2007 284 288
31. B.C. Tieu, C. Lee, H. Sun, W. Lejeune, A. Recinos III, and X. Ju et al. An adventitial IL-6/MCP1 amplification loop accelerates macrophage-mediated vascular inflammation leading to aortic dissection in mice J Clin Invest 119 12 2009 3637 3651
32. S.J. Jenkins, D. Ruckerl, P.C. Cook, L.H. Jones, F.D. Finkelman, and N. van Rooijen et al. Local macrophage proliferation, rather than recruitment from the blood, is a signature of TH2 inflammation Science 332 6035 2011 1284 1288
33. L.C. Davies, M. Rosas, S.J. Jenkins, C.T. Liao, M.J. Scurr, and F. Brombacher et al. Distinct bone marrow-derived and tissue-resident macrophage lineages proliferate at key stages during inflammation Nat Commun 4 2013 1886
34. H. Sako, S. Miura, A. Iwata, H. Nishikawa, A. Kawamura, and K. Matsuo et al. Changes in CCR2 chemokine receptor expression and plasma MCP-1 concentration after the implantation of bare metal stents versus sirolimus-eluting stents in patients with stable angina Intern Med 47 1 2008 7 13
35. A. Heredia, A. Amoroso, C. Davis, N. Le, E. Reardon, and J.K. Dominique et al. Rapamycin causes down-regulation of CCR5 and accumulation of anti-HIV beta-chemokines: an approach to suppress R5 strains of HIV-1 Proc Natl Acad Sci U S A 100 18 2003 10411 10416
36. R. Baetta, A. Granata, M. Canavesi, N. Ferri, L. Arnaboldi, and S. Bellosta et al. Everolimus inhibits monocyte/macrophage migration in vitro and their accumulation in carotid lesions of cholesterol-fed rabbits J Pharmacol Exp Ther 328 2 2009 419 425
37. N. Miyama, M.M. Dua, J.J. Yeung, G.M. Schultz, T. Asagami, and E. Sho et al. Hyperglycemia limits experimental aortic aneurysm progression J Vasc Surg 52 4 2010 975 983
38. Q. Zhao, K. Egashira, S. Inoue, M. Usui, S. Kitamoto, and W. Ni et al. Vascular endothelial growth factor is necessary in the development of arteriosclerosis by recruiting/activating monocytes in a rat model of long-term inhibition of nitric oxide synthesis Circulation 105 9 2002 1110 1115
39. S. Shantikumar, R. Ajjan, K.E. Porter, and D.J. Scott Diabetes and the abdominal aortic aneurysm Eur J Vasc Endovasc Surg 39 2 2010 200 207
40. M.M. Tedesco, M. Terashima, F.G. Blankenberg, Z. Levashova, J.M. Spin, and M.V. Backer et al. Analysis of in situ and ex vivo vascular endothelial growth factor receptor expression during experimental aortic aneurysm progression Arterioscler Thromb Vasc Biol 29 10 2009 1452 1457
41. E. Choke, M.M. Thompson, J. Dawson, W.R. Wilson, S. Sayed, and M.I. Loftus et al. Abdominal aortic aneurysm rupture is associated with increased medial neovascularization and overexpression of proangiogenic cytokines Arterioscler Thromb Vasc Biol 26 9 2006 2077 2082
42. H. Kaneko, T. Anzai, T. Takahashi, T. Kohno, M. Shimoda, and A. Sasaki et al. Role of vascular endothelial growth factor-A in development of abdominal aortic aneurysm Cardiovasc Res 91 2 2011 358 367
43. E. Choke, G.W. Cockerill, J. Dawson, F. Howe, W.R. Wilson, and I.M. Loftus et al. Vascular endothelial growth factor enhances angiotensin II-induced aneurysm formation in apolipoprotein E-deficient mice J Vasc Surg 52 1 2010 159-66.e1
44. M.A. Dery, M.D. Michaud, and D.E. Richard Hypoxia-inducible factor 1: regulation by hypoxic and non-hypoxic activators Int J Biochem Cell Biol 37 3 2005 535 540
45. C. Brahimi-Horn, N. Mazure, and J. Pouyssegur Signalling via the hypoxia-inducible factor-1alpha requires multiple posttranslational modifications Cell Signal 17 1 2005 1 9
46. C.S. Lim, S. Kiriakidis, A. Sandison, E.M. Paleolog, and A.H. Davies Hypoxia-inducible factor pathway and diseases of the vascular wall J Vasc Surg 58 1 2013 219 230
47. D. Koole, H.J. Zandvoort, A. Schoneveld, A. Vink, J.A. Vos, and L.L. van den Hoogen et al. Intraluminal abdominal aortic aneurysm thrombus is associated with disruption of wall integrity J Vasc Surg 57 1 2013 77 83
48. K. Satoh, P. Nigro, T. Matoba, M.R. O'Dell, Z. Cui, and X. Shi et al. Cyclophilin A enhances vascular oxidative stress and the development of angiotensin II-induced aortic aneurysms Nat Med 15 6 2009 649 656
49. L. Zhao, M.P. Moos, R. Gräbner, F. Pédrono, J. Fan, and B. Kaiser et al. The 5-lipoxygenase pathway promotes pathogenesis of hyperlipidemia-dependent aortic aneurysm Nat Med 10 9 2004 966 973
50. O.J. Erdozain, S. Pegrum, V.R. Winrow, M. Horrocks, and C.R. Stevens Hypoxia in abdominal aortic aneurysm supports a role for HIF-1alpha and Ets-1 as drivers of matrix metalloproteinase upregulation in human aortic smooth muscle cells J Vasc Res 48 2 2011 163 170
51. H. Zhang, D.Z. Qian, Y.S. Tan, K. Lee, P. Gao, and Y.R. Ren et al. Digoxin and other cardiac glycosides inhibit HIF-1alpha synthesis and block tumor growth Proc Natl Acad Sci U S A 105 50 2008 19579 19586
52. T. Yamaguchi, M. Yokokawa, M. Suzuki, S. Higashide, Y. Katoh, and S. Sugiyama et al. The effect of immunosuppression on aortic dilatation in a rat aneurysm model Surg Today 30 12 2000 1093 1099
53. P.B. Dobrin, N. Baumgartner, S. Anidjar, G. Chejfec, and R. Mrkvicka Inflammatory aspects of experimental aneurysms. Effect of methylprednisolone and cyclosporine Ann N Y Acad Sci 800 1996 74 88
54. J.H. Lindeman, T.J. Rabelink, and J.H. van Bockel Immunosuppression and the abdominal aortic aneurysm: Doctor Jekyll or Mister Hyde? Circulation 124 18 2011 e463 e465
55. M.J. Englesbe, A.H. Wu, A.W. Clowes, and R.E. Zierier The prevalence and natural history of aortic aneurysms in heart and abdominal organ transplant patients J Vasc Surg 37 1 2003 27 31
56. W. Xiong, Y. Zhao, A. Prall, T.C. Greiner, and B.T. Baxter Key roles of CD4+ T cells and IFN-gamma in the development of abdominal aortic aneurysms in a murine model J Immunol 172 4 2004 2607 2612
57. H. Ait-Oufella, Y. Wang, O. Herbin, S. Bourcier, S. Potteaux, and J. Joffre et al. Natural regulatory T cells limit angiotensin ii-induced aneurysm formation and rupture in mice Arterioscler Thromb Vasc Biol 33 10 2013 2374 2379
58. M. Yin, J. Zhang, Y. Wang, S. Wang, D. Böckler, and Z. Duan et al. Deficient CD4+CD25+ T regulatory cell function in patients with abdominal aortic aneurysms Arterioscler Thromb Vasc Biol 30 9 2010 1825 1831
59. E. Kaschina, F. Schrader, M. Sommerfeld, U.R. Kemnitz, A. Grzesiak, and M. Krikov et al. Telmisartan prevents aneurysm progression in the rat by inhibiting proteolysis, apoptosis and inflammation J Hypertens 26 12 2008 2361 2373
60. J.A. Kim, H.J. Jang, L.A. Martinez-Lemus, and J.R. Sowers Activation of mTOR/p70S6 kinase by ANG II inhibits insulin-stimulated endothelial nitric oxide synthase and vasodilation Am J Physiol Endocrinol Metab 302 2 2012 E201 E208
61. S. Hafizi, X. Wang, A.H. Chester, M.H. Yacoub, and C.G. Proud ANG II activates effectors of mTOR via PI3-K signaling in human coronary smooth muscle cells Am J Physiol Heart Circ Physiol 287 3 2004 H1232 H1238